FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W16180300> ?p ?o ?g. }

• W16180300 endingPage "185" @default.
• W16180300 startingPage "169" @default.
• W16180300 abstract "Malignant gliomas remain among the most treatment-refractory tumors. Traditional upfront treatment regimens have incorporated nitrosurea-based chemotherapy. This strategy has evolved to include temozolomide-based approaches. Promising Phase I/II data with TMZ in the recurrent setting prompted a Phase III EORTC study of TMZ in combination with RT for patients with newly diagnosed GBM. The landmark EORTC 26981-22981/NCIC CE3 study demonstrated a significant improvement in not only median survival, but also in terms of 2-year survival. Given that over one-quarter of the patients enrolled on the TMZ + RT arm survived beyond 2-years, there appears to be a finite percentage of patients who derive long-term benefit from this treatment regimen. Given that the EORTC-based regimen represents an incremental improvement in the standard of care, rather than a truly curative solution for most patients, further efforts must be expended to identify novel therapeutic approaches. To this end, targeted therapies have emerged as an attractive option. Accumulating evidence suggests that certain molecular pathways are selectively upregulated in tumor vs. normal cells. Some of these pathways have been shown to be instrumental in proliferation, migration, invasion, angiogenesis, and/or survival in preclinical models. These would appear to represent ideal therapeutic targets, as their antagonism may lead to an improvement in the therapeutic ratio of radiation. Emerging data from clinical studies on first generation targeted therapies appear to demonstrate benefit for select patients. Further molecular/genetic profiling must be undertaken to identify exactly which patients benefit." @default.
• W16180300 created "2016-06-24" @default.
• W16180300 creator A5018381770 @default.
• W16180300 creator A5026878273 @default.
• W16180300 date "2008-01-01" @default.
• W16180300 modified "2023-10-14" @default.
• W16180300 title "Overcoming Therapeutic Resistance in Malignant Gliomas: Current Practices and Future Directions" @default.
• W16180300 cites W120570196 @default.
• W16180300 cites W1481003824 @default.
• W16180300 cites W1536266814 @default.
• W16180300 cites W1798597715 @default.
• W16180300 cites W1968184782 @default.
• W16180300 cites W1977392502 @default.
• W16180300 cites W1999805805 @default.
• W16180300 cites W2001598945 @default.
• W16180300 cites W2010174111 @default.
• W16180300 cites W2010677999 @default.
• W16180300 cites W2012441637 @default.
• W16180300 cites W2022039302 @default.
• W16180300 cites W2032294682 @default.
• W16180300 cites W2053535808 @default.
• W16180300 cites W2058355285 @default.
• W16180300 cites W2067471596 @default.
• W16180300 cites W2070151637 @default.
• W16180300 cites W2075338210 @default.
• W16180300 cites W2079786467 @default.
• W16180300 cites W2088925558 @default.
• W16180300 cites W2096287682 @default.
• W16180300 cites W2105100844 @default.
• W16180300 cites W2113012900 @default.
• W16180300 cites W2114998237 @default.
• W16180300 cites W2117941094 @default.
• W16180300 cites W2123099415 @default.
• W16180300 cites W2125096000 @default.
• W16180300 cites W2126890008 @default.
• W16180300 cites W2129873928 @default.
• W16180300 cites W2136527161 @default.
• W16180300 cites W2139008103 @default.
• W16180300 cites W2143739956 @default.
• W16180300 cites W2144801963 @default.
• W16180300 cites W2161965319 @default.
• W16180300 cites W2167713837 @default.
• W16180300 cites W2169332099 @default.
• W16180300 cites W2332800771 @default.
• W16180300 cites W2388163742 @default.
• W16180300 cites W4231413394 @default.
• W16180300 cites W4231637567 @default.
• W16180300 cites W4238578641 @default.
• W16180300 cites W4242397642 @default.
• W16180300 cites W4249136412 @default.
• W16180300 cites W4252178897 @default.
• W16180300 cites W4253261674 @default.
• W16180300 doi "https://doi.org/10.1007/978-0-387-36744-6_9" @default.
• W16180300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18236717" @default.
• W16180300 hasPublicationYear "2008" @default.
• W16180300 type Work @default.
• W16180300 sameAs 16180300 @default.
• W16180300 citedByCount "10" @default.
• W16180300 countsByYear W161803002012 @default.
• W16180300 countsByYear W161803002014 @default.
• W16180300 countsByYear W161803002015 @default.
• W16180300 countsByYear W161803002018 @default.
• W16180300 countsByYear W161803002023 @default.
• W16180300 crossrefType "book-chapter" @default.
• W16180300 hasAuthorship W16180300A5018381770 @default.
• W16180300 hasAuthorship W16180300A5026878273 @default.
• W16180300 hasConcept C126322002 @default.
• W16180300 hasConcept C143998085 @default.
• W16180300 hasConcept C2776694085 @default.
• W16180300 hasConcept C2777389519 @default.
• W16180300 hasConcept C2778227246 @default.
• W16180300 hasConcept C2780964509 @default.
• W16180300 hasConcept C2781413609 @default.
• W16180300 hasConcept C502942594 @default.
• W16180300 hasConcept C509974204 @default.
• W16180300 hasConcept C535046627 @default.
• W16180300 hasConcept C71924100 @default.
• W16180300 hasConceptScore W16180300C126322002 @default.
• W16180300 hasConceptScore W16180300C143998085 @default.
• W16180300 hasConceptScore W16180300C2776694085 @default.
• W16180300 hasConceptScore W16180300C2777389519 @default.
• W16180300 hasConceptScore W16180300C2778227246 @default.
• W16180300 hasConceptScore W16180300C2780964509 @default.
• W16180300 hasConceptScore W16180300C2781413609 @default.
• W16180300 hasConceptScore W16180300C502942594 @default.
• W16180300 hasConceptScore W16180300C509974204 @default.
• W16180300 hasConceptScore W16180300C535046627 @default.
• W16180300 hasConceptScore W16180300C71924100 @default.
• W16180300 hasLocation W161803001 @default.
• W16180300 hasLocation W161803002 @default.
• W16180300 hasOpenAccess W16180300 @default.
• W16180300 hasPrimaryLocation W161803001 @default.
• W16180300 hasRelatedWork W2046593071 @default.
• W16180300 hasRelatedWork W2073885660 @default.
• W16180300 hasRelatedWork W2152636851 @default.
• W16180300 hasRelatedWork W2163845360 @default.
• W16180300 hasRelatedWork W2324032012 @default.
• W16180300 hasRelatedWork W2347438058 @default.

• next